Responses
Clinical
Original article
HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women
Compose a Response to This Article
Other responses
No responses have been published for this article.